Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Income from Continuing Operations (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Income from Continuing Operations for 16 consecutive years, with 4462000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 75.84% year-over-year to 4462000.0, compared with a TTM value of 94432000.0 through Dec 2025, up 18.11%, and an annual FY2025 reading of 94432000.0, up 18.11% over the prior year.
  • Income from Continuing Operations was 4462000.0 for Q4 2025 at Orthofix Medical, up from 22795000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 16081000.0 in Q4 2022 and bottomed at 60938000.0 in Q1 2023.
  • Average Income from Continuing Operations over 5 years is 19431150.0, with a median of 20321000.0 recorded in 2023.
  • The sharpest move saw Income from Continuing Operations soared 163.55% in 2022, then crashed 1684.01% in 2023.
  • Year by year, Income from Continuing Operations stood at 25304000.0 in 2021, then skyrocketed by 163.55% to 16081000.0 in 2022, then plummeted by 237.89% to 22174000.0 in 2023, then grew by 16.71% to 18468000.0 in 2024, then surged by 75.84% to 4462000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for OFIX at 4462000.0 in Q4 2025, 22795000.0 in Q3 2025, and 14081000.0 in Q2 2025.